Detalhe da pesquisa
1.
New Therapies for Type 1 and Type 2 Hereditary Angioedema.
N Engl J Med;
2024 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38819650
2.
The autoimmune rheumatological presentation of Common Variable Immunodeficiency Disorders with an overview of genetic testing.
Semin Arthritis Rheum;
65: 152387, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38330740
3.
CRISPR-Cas9 In Vivo Gene Editing of KLKB1 for Hereditary Angioedema.
N Engl J Med;
390(5): 432-441, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38294975
4.
Uncovering the true burden of hereditary angioedema due to C1-inhibitor deficiency: A focus on the Asia-Pacific region.
J Allergy Clin Immunol;
153(1): 42-54, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37898409
5.
A Review of Randomized Controlled Trials of Hereditary Angioedema Long-Term Prophylaxis with C1 Inhibitor Replacement Therapy: Alleviation of Disease Symptoms Is Achievable.
J Asthma Allergy;
16: 269-277, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36922963
6.
An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trial.
Lancet;
401(10375): 458-469, 2023 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36774155
7.
Treatment of hereditary angioedema-single or multiple pathways to the rescue.
Front Allergy;
3: 952233, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36172291
8.
The Icatibant Outcome Survey: 10 years of experience with icatibant for patients with hereditary angioedema.
Clin Exp Allergy;
52(9): 1048-1058, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35861129
9.
An Antisense Oligonucleotide for Hereditary Angioedema.
N Engl J Med;
386(11): 1083-1085, 2022 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35294818
10.
The Role of Herpes Viruses in Pulmonary Fibrosis.
Front Med (Lausanne);
8: 704222, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34368196
11.
Assessment and management of disease burden and quality of life in patients with hereditary angioedema: a consensus report.
Allergy Asthma Clin Immunol;
17(1): 40, 2021 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33875020
12.
Managing Chronic Urticaria and Recurrent Angioedema Differently with Advancing Age.
J Allergy Clin Immunol Pract;
9(6): 2186-2194, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33819638
13.
Impact of lanadelumab on health-related quality of life in patients with hereditary angioedema in the HELP study.
Allergy;
76(4): 1188-1198, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33258114
14.
Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks.
Allergy;
75(11): 2879-2887, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32452549
15.
Subcutaneous C1 inhibitor for prevention of attacks of hereditary angioedema: additional outcomes and subgroup analysis of a placebo-controlled randomized study.
Allergy Asthma Clin Immunol;
15: 49, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31485239
16.
Elderly versus younger patients with hereditary angioedema type I/II: patient characteristics and safety analysis from the Icatibant Outcome Survey.
Clin Transl Allergy;
9: 37, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31360439
17.
Hereditary angioedema: an update on causes, manifestations and treatment.
Br J Hosp Med (Lond);
80(7): 391-398, 2019 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31283393
18.
Pediatricians diagnosed few patients with childhood-presented hereditary angioedema: Icatibant Outcome Survey findings.
J Allergy Clin Immunol Pract;
7(3): 1078-1080, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30170163
19.
Lanadelumab for the Prophylactic Treatment of Hereditary Angioedema with C1 Inhibitor Deficiency: A Review of Preclinical and Phase I Studies.
BioDrugs;
33(1): 33-43, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30539362
20.
Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical Trial.
JAMA;
320(20): 2108-2121, 2018 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30480729